Fed. Circ. Won't Revive Colitis Patent Axed By PTAB
The Patent Trial and Appeal Board rightly invalidated claims from a patent covering Salix Pharmaceuticals' ulcerative colitis treatment Apriso following a challenge from Mylan Pharmaceuticals Inc., the Federal Circuit said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article